Accessibility Menu
 

Raphael Pharmaceutical

(OTC) RAPH

Current Price$1.40
Market Cap$27.48M
Since IPO (2023)-36%
5 YearN/A
1 Year+40%
1 Month+0%

Raphael Pharmaceutical Financials at a Glance

Market Cap

$27.48M

Revenue (TTM)

$0.00

Net Income (TTM)

$1.47M

EPS (TTM)

$-0.07

P/E Ratio

-19.34

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.40

Volume

111

Open

$1.40

Previous Close

$1.40

Daily Range

$1.40 - $1.40

52-Week Range

$0.04 - $1.40

RAPH News

No articles available.

RAPH: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Raphael Pharmaceutical

Industry

Biotechnology

CEO

Shlomo Pilo

Headquarters

Jaffa, 6803605, IL

RAPH Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

0%

Return on Capital

1%

Return on Assets

-210%

Earnings Yield

-5.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$27.48M

Shares Outstanding

19.63M

Volume

111

Short Interest

0.00%

Avg. Volume

6.533

Financials (TTM)

Gross Profit

$0.00

Operating Income

$1.51M

EBITDA

$1.51M

Operating Cash Flow

$532.00K

Capital Expenditure

$0.00

Free Cash Flow

$532.00K

Cash & ST Invst.

$19.00K

Total Debt

$41.00K

Raphael Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$27.48M

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

$322.00K

-29.8%

EBITDA

$315.00K

-26.5%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$3.00K

-92.5%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-210.29%

N/A

Return on Invested Capital

1.15%

N/A

Free Cash Flow

$171.00K

N/A

Operating Cash Flow

$171.00K

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GBLPGlobal Pharmatech, Inc.
$0.05+0.00%
EMITFElbit Imaging Ltd.
$1.80+20.00%
MEDIFMediPharm Labs Corp.
$0.05-3.11%
VYYRFVoyageur Pharmaceuticals Ltd.
$0.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
TAT&T
$28.31+0.02%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%
INFYInfosys
$13.12+0.01%

Questions About RAPH

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.